ITMS950008A1 - Composto farmaceutico di vitamine e acidi grassi naturali per la cura sintomatica della sindrome premestruale e della dismenorrea - Google Patents
Composto farmaceutico di vitamine e acidi grassi naturali per la cura sintomatica della sindrome premestruale e della dismenorrea Download PDFInfo
- Publication number
- ITMS950008A1 ITMS950008A1 IT95MS000008A ITMS950008A ITMS950008A1 IT MS950008 A1 ITMS950008 A1 IT MS950008A1 IT 95MS000008 A IT95MS000008 A IT 95MS000008A IT MS950008 A ITMS950008 A IT MS950008A IT MS950008 A1 ITMS950008 A1 IT MS950008A1
- Authority
- IT
- Italy
- Prior art keywords
- fatty acids
- dysmenorrhea
- pharmaceutical compound
- premenstrual syndrome
- symptomatic treatment
- Prior art date
Links
- 206010036618 Premenstrual syndrome Diseases 0.000 title claims abstract description 10
- 150000001875 compounds Chemical class 0.000 title claims abstract description 9
- 206010013935 Dysmenorrhoea Diseases 0.000 title claims abstract description 8
- 208000005171 Dysmenorrhea Diseases 0.000 title claims abstract description 6
- 238000002636 symptomatic treatment Methods 0.000 title claims abstract description 6
- 229930003231 vitamin Natural products 0.000 title claims description 5
- 235000013343 vitamin Nutrition 0.000 title claims description 5
- 239000011782 vitamin Substances 0.000 title claims description 5
- 229940088594 vitamin Drugs 0.000 title claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 title description 5
- 239000000194 fatty acid Substances 0.000 title description 5
- 229930195729 fatty acid Natural products 0.000 title description 5
- 150000004665 fatty acids Chemical class 0.000 title description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 5
- 235000008390 olive oil Nutrition 0.000 claims abstract description 4
- 239000004006 olive oil Substances 0.000 claims abstract description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract description 4
- 235000008160 pyridoxine Nutrition 0.000 claims abstract description 4
- 239000011677 pyridoxine Substances 0.000 claims abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 150000003180 prostaglandins Chemical class 0.000 claims description 5
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 4
- 230000000202 analgesic effect Effects 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010006313 Breast tenderness Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000005485 Thrombocytosis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001944 accentuation Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003431 anti-prostaglandin Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 208000001118 melena Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MS000008A ITMS950008A1 (it) | 1995-10-23 | 1995-10-23 | Composto farmaceutico di vitamine e acidi grassi naturali per la cura sintomatica della sindrome premestruale e della dismenorrea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MS000008A ITMS950008A1 (it) | 1995-10-23 | 1995-10-23 | Composto farmaceutico di vitamine e acidi grassi naturali per la cura sintomatica della sindrome premestruale e della dismenorrea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMS950008A0 ITMS950008A0 (cs) | 1995-10-23 |
| ITMS950008A1 true ITMS950008A1 (it) | 1997-04-23 |
Family
ID=11387220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT95MS000008A ITMS950008A1 (it) | 1995-10-23 | 1995-10-23 | Composto farmaceutico di vitamine e acidi grassi naturali per la cura sintomatica della sindrome premestruale e della dismenorrea |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | ITMS950008A1 (cs) |
-
1995
- 1995-10-23 IT IT95MS000008A patent/ITMS950008A1/it not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ITMS950008A0 (cs) | 1995-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4970076A (en) | Fatty acid composition | |
| Zuo et al. | Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats | |
| Liao et al. | Naotaifang formula attenuates OGD/R-induced inflammation and ferroptosis by regulating microglial M1/M2 polarization through BMP6/SMADs signaling pathway | |
| Dyall et al. | Omega‐3 fatty acids reverse age‐related decreases in nuclear receptors and increase neurogenesis in old rats | |
| Cohen et al. | A radioimmunoassay determination of the concentrations of prostaglandins E2 and F2α in painful and asymptomatic human dental pulps | |
| Tazi et al. | Treatment of cachexia in oncology | |
| US4058594A (en) | Immuno-suppressive agents | |
| Mohebbati et al. | Protective effects of long-term administration of Ziziphus jujuba fruit extract on cardiovascular responses in L-NAME hypertensive rats | |
| EP0222483A2 (en) | Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of endometriosis | |
| JPS6038324A (ja) | 脂肪酸組成物 | |
| US3993775A (en) | Immuno-suppressive agents | |
| JPH02104522A (ja) | 脂肪酸を含有する医薬用組成物 | |
| RU2122408C1 (ru) | Лечение жирными кислотами | |
| ITRM970594A1 (it) | Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo | |
| ITMS950008A1 (it) | Composto farmaceutico di vitamine e acidi grassi naturali per la cura sintomatica della sindrome premestruale e della dismenorrea | |
| Hattori et al. | Studies on the antinephritic effect of plant components (4): reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis | |
| US5789446A (en) | Therapeutic agent for treating joint diseases associated with arthritis | |
| JPS6330416A (ja) | 脳循環代謝改善剤 | |
| US7374785B1 (en) | Composition for a feeling of calmness | |
| IE54557B1 (en) | Pharmaceutical and dietary composition | |
| Wang et al. | Saikosaponin A alleviates rat liver fibrosis by inhibiting Hedgehog signaling pathway-mediated autophagy and NLRP3 inflammasome | |
| Vardi et al. | Prostaglandins and their synthesis inhibitors in migraine | |
| de Vasconcelos et al. | Role of endothelial nitric oxide synthase in cerebral blood flow changes during kainate seizures: a genetic approach using knockout mice | |
| KR20210056283A (ko) | 대두 추출물을 포함하는 불면증 예방 또는 치료용 조성물 및 이의 제조방법 | |
| Sametz et al. | Influence of a diet rich in eicosapentaenoic acid on the development of rat paw oedema and on the formation of prostaglandins I2 and E2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0002 | Rejected |